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Different Mechanisms of Calcitonin, Calcitonin Gene-Related Peptide,
and Somatostatin Regulation by Glucocorticoids in a Cell Culture of
Human Medullary Thyroid Carcinoma
Gilbert J. Cote, and Robert F. Gagel*

We have employed the TT cell line, a model for the human medullary thyroid carcinoma cell, lo study
the regulation of peptide hormone production by glucocorticoids. Complementary DNA probes were
used to measure the calcitonin (CT), CT gene-related peptide (CGRP), and somatostatin (SRIF)
mRNA levels. Dose-response experiments in serum-free medium showed that dexamethasone (six-day
treatment) lowered somatostatin (to 1% of basal) and CGRP mRNA (to 50% of basal) and stimulated
CT mRNA (threefold to thirteenfold) with a half-maximal effective concentration of 10 " M. Time
course studies for cells continuously exposed to 70" M dexamethasone showed a rapid (within hours)
lowering of SRIF mRNA. whereas the effects on CT and CGRP mRNA required six to eight days. These
results demonstrate the presence of two mechanisms, transcriptional (somatostatin) and
posttranscriptional (the RNA splice decision to make CT or CGRP mRNA). that can be hormonally
regulated. (Henry Ford Hosp MedJ 1987;35:149-52)

T

he TT cell line is a continuous cell line originally derived
from the needle biopsy of a human medullary thyroid carcinoma (1). We have employed this cell line to study the production of the peptide hormones calcitonin (CT), CT gene-related
peptide (CGRP), and somatostatin (SRIF), Two precursor peptides for CT and CGRP are produced from the CT gene by alternative RNA processing, whereas the SRIF gene codes for the
production of a single precursor peptide (2,3). Because the TT
cell line produces all three of these peptides in significant quantities, it provides a useful model system for studying the regulation ofthe two genes. We have previously demonstrated an
effect of the synthetic glucocorticoid dexamethasone on
production of SRIF (4), as well as CT and CGRP (5). In this paper we present and compare the effects of dexamethasone treatment on CT, CGRP and SRIF mRNA in the TT cell line. The
results demonstrate the existence of two distinct mechanisms of
action for dexamethasone: a rapid transcriptional effect seen on
SRIF, and a more slowly developing posttranscriptional effect
on the processing of primary RNA transcript derived from the
CT gene.

Experimental Procedures
Cell culture methodology
The TT cells were maintained in RPMI 1640 medium supplemented with 10% fetal calf semm (Gibco Laboratories, Grand
Island, NY), using previously described techniques (6). In
experiments using semm-free medium, cells were subcultured
48 hours before treatment in serum-containing medium and
then switched to semm-free medium 24 hours before the onset
of treatment. Serum-free defined medium was prepared as
previously described for a rat C-cell line (7), Cell counts were
determined with the aid of a Coulter Counter (model ZF), as pre-
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viously described (6). All steroids were added to the medium as
25 mM stocks prepared in ethanol. Control cells received an
equal volume of ethanol.
Preparation of RNA
The TT cells were plated at an initial density of ~3 x 10*"
cells/100 mm dish. The cells were allowed to attach for 24 hours
before treatment. Total cellular RNA was isolated from various
cell types by the guanidine isothiocyanate procedure (8), with
the previously described modifications (5). Total RNA was
stored dissolved in sterile distilled H^O in the presence of
vanadium-riboside complex (9) at -70°C.
Hybridizations
RNA dot blot hybridizations were performed by immobilization of purified total RNA onto nitrocellulose paper as described
by Thomas (10). The SRIF-, CT-, and CGRP-specific probes
were prepared as previously described (4,5). Prehybridization,
hybridization, and washing procedures were identical to those of
Thomas (10). Autoradiographs were quantitated by computerassisted densitometric scanning with a video camera as described by Mariash et al (11).

Results
Fig 1 shows the effect of a pharmacologic dose of dexamethasone (10-* M) on CT, CGRP, and SRIF mRNA levels.
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Fig 1—Time course of dexamethasone treatment on CT. CGRP.
and SRIF mRNA production in the TT cells. The TT cells were
plated at an initial density of ~3 X 70* cells/100 mm dish and
allowed to attach in growth medium (24 hours) before changing
to medium containing I x 70 * M dexamethasone. Medium
was changed at 48-hour intervals. RNA measurements were
made at indicated time points after the initiation of treatment by
removal of medium and addition of guanidine isothiocyanate.
The values represent the average hybridization value of two
dishes as determined by dot hybridization and quantitated by a
computer-assisted densitometer.
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Fig 2—Dose-response curve for the effect of dexamethasone on
CT. CGRP, and SRIF mRNA production. The TT cells were
plated at an initial density of ~3 X ICP cells/100 mm dish in
serum-containing medium for 24 hours, then switched to serumfree medium for 24 hours before treatment. Cells were then
grown in the presence of the indicated concentration of dexamethasone in serum-free medium for six days with medium
changed at 48-hour intervals. The mRNA levels were determined as described in Fig 1.

mechanisms in the human medullary thyroid carcinoma TT cell
Dexamethasone treatment affected the levels of each mRNA difline. Three possible points of regulation are transcription, RNA
ferently. The levels of SRIF mRNA showed a rapid decrease
processing, and mRNA degradation. Fig 3 schematically dem(levels reach 50% of control by 12 hours) and were barely detectonstrates the production of CT, CGRP and SRIF mRNA from
able by 48 hours. While CGRP mRNA levels also declined as a
their respective genes. The SRIF gene is transcribed, the tranresult of dexamethasone treatment, a six-day treatment was rescript undergoes RNA processing in the nucleus to produce maquired to achieve a 50% reduction. Unlike SRIF and CGRP, CT
ture
mRNA, and then the mRNA is typically degraded in the
mRNA showed an increase over two to eight days following
cytoplasm
after several rounds of translation. Unlike the SRIF
treatment with dexamethasone. Although this increase could be
gene,
the
CT
gene's primary transcript is altematively processed
explained by an enhancement of transcription, the rate ofthe reto
produce
one
of two possible mRNAs, one coding for CT and
sponse and the simultaneous decrease in CGRP mRNA levels
the
other
for
CGRP
Therefore, RNA processing becomes a key
suggest a more complex explanation.
regulatory
step
in
the
production of CT and CGRP mRNA,
To determine whether glucocorticoids might play a physiologically significant role in the regulation of these genes, we exEffect of dexamethasone on SRIF mRNA levels
amined the dose-dependent effects of dexamethasone on CT,
We have shown that dexamethasone rapidly lowered SRIF
CGRP and SRIF mRNA levels (Fig 2). Again, both SRIF and
mRNA levels. Because the ~ 12-hour half-life of the SRIF
CGRP mRNA levels were depressed, while CT levels were
mRNA (data not shown) approximates the rate of decline in
enhanced. The TT cells are typically grown in the presence of
SRIF mRNA following dexamethasone treatment, we favor a
10% fetal bovine serum, which we have found to contain apmodel whereby dexamethasone acts to inhibit directiy the tranproximately 10 M endogenous steroid. For this reason, the
scription ofthe SRIF gene. The possibility that dexamethasone
dose-response curves were generated in serum-free medium.
affects SRIF mRNA stability, though unlikely, has not been
The half-maximal doses of dexamethasone (10' M for CT, 10'*
excluded.
M for CGRP, and 10" M for SRIF mRNA) are shifted
two orders of magnitude to the left, compared to our previous
findings in the presence of serum (4,5), and now approach phys- Effect of dexamethasone on CT and CGRP mRNA levels
iologically significant levels (12).
Dexamethasone acts to enhance CT mRNA levels and decrease CGRP mRNA levels. Regulation of this event must occur
at either the RNA processing step or at the level of mRNA degDiscussion
radation. Transcriptional regulation alone would result in parDifferences between regulation ofthe CT and SRIF genes
allel changes in CT and CGRP mRNA levels, such as seen after
The results presented in this and previous papers (4,5) sugphorbol ester or cAMP analog treatment (12), and not the divergest that dexamethasone acts to regulate mRNA levels by several
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Fig 3—Schematic outline comparing RNA processing of the primary transcript from the SRIF gene and the CT gene: A) processing ofthe SRIF gene primary transcript to SRIF mRNA, and
B) processing of the CT gene primary transcript into CT and
CGRP mRNA.

gence seen here. We have previously demonstrated that dexamethasone has no effect on the half-life of either CT or CGRP
mRNA (5). Therefore, we proposed that dexamethasone must
be acting to affect the RNA processing of the primary transcript.
How might dexamethasone alter the RNA processing of the
primary transcript of the CT gene? The first possibility to consider is a direct effect of dexamethasone on RNA processing.
The dexamethasone-glucocorticoid receptor complex, or some
other dexamethasone-binding protein with regulatory abilities,
might affect RNA processing directly. Glucocorticoid receptors
have been demonstrated to bind RNA (13), and RNA processing
is brought about by protein-RNA complexes (14). However, it is
unlikely that dexamethasone is acting through one of these direct mechanisms, because the time course for the effect is too
slow, and a similar effect can be produced in the absence of any
steroids by long-term culturing of the cells without subculturing
(as described by A. deBustros et al at these proceedings). Therefore, we propose that dexamethasone is acting in an indirect
fashion to alter RNA processing.
Model for the regulation of alternative RNA processing
by dexamethasone
To explain the regulation of the altemative processing of the
CT gene primary transcript, we favor a model where the production of CT mRNA is the unregulated pathway or "null" choice,
and production of CGRP mRNA requires the presence of specific factor(s). This model is based on the available information
regarding the processing of the CT gene transcript (15) and on
current theories of RNA processing (14). From this model we
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predict that in the thyroid C-cell, cleavage and polyadenylation
at the site immediately following the CT exon are the early steps
which necessitate an exon 3 to CT exon splice (Fig 3). If our CT
"null" choice is correct, then the production of CGRP mRNA
would require that: 1) polyadenylation immediately after the CT
exon be blocked; and 2) because the blockage of cleavage following the CT exon would be insufficient to ensure CGRP
mRNA production, a mechanism must exist to prevent an exon 3
to CT exon splice. This is most easily accomplished either by
preventing branch point formation within the third intron or
by blocking the accessibility of the 3' splice junction (studies
have shown that spliceosome binding to the 3' splice site is required for 5' cleavage) (14). This blockage would then allow
preferential usage of the next available 3' splice junction (at the
CGRP exon).
This model would predict the existence of protein or RNA
factor(s) in CGRP-producing cell types functioning to block
polyadenylation immediately after the CT exon and removal of
the intron immediately before the CT exon. Whether this is accomplished by a single factor, several factors, or a complex remains to be elucidated. One such way in which the interaction
could occur is diagramed in Fig 4, where separate binding sites
cause the RNA to loop out while forcing CGRP mRNA production. If the production of this complex was inhibited by
dexamethasone, cell cycle-dependent or cell type-dependent
mechanisms, then the production of CT would be favored.
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